Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidyl-tRNA hydrolase 1 homolog (PTRH1) is an enzyme localized mainly in the mitochondria that plays a critical role in maintaining translation fidelity and cellular protein homeostasis by cleaving peptidyl-tRNAs which have dissociated prematurely from stalled ribosomes or which are not stably fixed in the ribosomal P-site[1][4]. This enzymatic activity helps to recycle tRNA molecules and prevent the accumulation of peptidyl-tRNA species that could otherwise be cytotoxic or interfere with further rounds of translation[1][3]. PTRH1 acts downstream of the ribosome-associated quality control (RQC) pathway and specifically hydrolyzes non-ubiquitinated nascent chains, thus acting as a safeguard to sustain efficient mitochondrial protein synthesis and cell viability[1][3]. Pathologically, mutations or dysregulation of PTRH1 have been associated with several diseases, including certain cancers and vascular skin diseases, underscoring its relevance in human health[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidyl-tRNA hydrolase 1 homolog (PTRH1).